2024-03-19T08:08:47Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_4DAFF0202FDC
2024-03-16T02:29:08Z
serval:BIB_4DAFF0202FDC
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.
10.1038/nrclinonc.2018.29
000430309500015
29508855
Fukumura
D.
author
Kloepper
J.
author
Amoozgar
Z.
author
Duda
D.G.
author
Jain
R.K.
author
article
review
2018-05
Nature reviews. Clinical oncology
1759-4782
1759-4774
journal
15
5
325-340
Angiogenesis Inhibitors/therapeutic use
Humans
Immunotherapy/trends
Neoplasms/drug therapy
Neoplasms/immunology
Neovascularization, Pathologic/drug therapy
Neovascularization, Pathologic/immunology
Tumor Microenvironment/drug effects
Tumor Microenvironment/immunology
Vascular Endothelial Growth Factor A/immunology
Vascular Endothelial Growth Factor A/therapeutic use
Vesicular Transport Proteins/immunology
Vesicular Transport Proteins/therapeutic use
eng
60_published
peer-reviewed
Publication types: Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
Publication Status: ppublish